| Up
2006P-0398:
Require Bioequivalence Studies for Generic or Follow-on Formulations
of MEGACE ES (megestrol acetate oral suspension 625 mg/5 ml)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
|
| |
ACK1 |
|
09/29/2006
|
|
09/29/2006
|
|
Federal Government |
|
FDA/DDM to Frommer
Lawrence & Haug, LLP |
|
|
|
|
|
|
|
pdf |
|
|
|
| |
|
|
Signature: |
|
Jennie Butler |
|
| |
| |
CP1 |
|
09/29/2006
|
|
09/29/2006
|
|
Private Industry
|
|
Frommer Lawrence
& Haug, LLP |
|
|
|
|
|
|
|
pdf
Attachments |
|
|
|
| |
Signature: |
|
Charles J. Raubicheck
|
|
| |
| |
C1 |
|
10/11/2006
|
|
10/05/2006
|
|
Individual Consumer
|
|
D Lowe
|
|
|
|
|
|
|
|
|
|
|
|
Top | Up
Page last updated
October 19, 2006
kk
Dockets Home Page | Dockets
Contacts and Location | Operating
Status | Item
Code Definitions | Federal
Register
FDA Home Page | Search
FDA Site | FDA A-Z Index
| Contact FDA
FDA/Dockets Management |